Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (501-510 of 706) with videos related to

Pageof 71
Sort By:
Circulation|November 18, 2005
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 TrialMarc S Sabatine, David A Morrow, Gilles Montalescot, et al.
European Heart Journal|April 15, 2014
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trialDaniel Lindholm, Christoph Varenhorst, Christopher P Cannon, et al.
American Heart Journal|October 6, 2018
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)Christopher P Cannon, Darren K McGuire, Richard Pratley, et al.
BMJ (Clinical Research Ed.)|June 21, 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trialStefan K James, Matthew T Roe, Christopher P Cannon, et al.
Archives of Internal Medicine|October 29, 2003
Predictors of hospital mortality in the global registry of acute coronary eventsChristopher B Granger, Robert J Goldberg, Omar Dabbous, et al.
European Heart Journal|July 3, 2004
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studiesDavid A Morrow, Elliott M Antman, Sabina A Murphy, et al.
American Journal of Hypertension|January 9, 2025
Continual Versus Occasional Blood Pressure (COOL-BP) in Remote Hypertension ManagementOzan Unlu, Christopher P Cannon, Simin Lee, et al.
Circulation|January 2, 2013
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO StudyPayal Kohli, Lars Wallentin, Eric Reyes, et al.
The American Journal of Medicine|November 28, 2013
NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic diseasePayal Kohli, Ph Gabriel Steg, Christopher P Cannon, et al.
European Heart Journal|August 2, 2011
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomesRobert F Storey, Richard C Becker, Robert A Harrington, et al.
Pageof 71

Showing results (501-510 of 706) with videos related to

Sort By:
Pageof 71
Circulation|November 18, 2005
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 TrialMarc S Sabatine, David A Morrow, Gilles Montalescot, et al.
European Heart Journal|April 15, 2014
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trialDaniel Lindholm, Christoph Varenhorst, Christopher P Cannon, et al.
American Heart Journal|October 6, 2018
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)Christopher P Cannon, Darren K McGuire, Richard Pratley, et al.
BMJ (Clinical Research Ed.)|June 21, 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trialStefan K James, Matthew T Roe, Christopher P Cannon, et al.
Archives of Internal Medicine|October 29, 2003
Predictors of hospital mortality in the global registry of acute coronary eventsChristopher B Granger, Robert J Goldberg, Omar Dabbous, et al.
European Heart Journal|July 3, 2004
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studiesDavid A Morrow, Elliott M Antman, Sabina A Murphy, et al.
American Journal of Hypertension|January 9, 2025
Continual Versus Occasional Blood Pressure (COOL-BP) in Remote Hypertension ManagementOzan Unlu, Christopher P Cannon, Simin Lee, et al.
Circulation|January 2, 2013
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO StudyPayal Kohli, Lars Wallentin, Eric Reyes, et al.
The American Journal of Medicine|November 28, 2013
NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic diseasePayal Kohli, Ph Gabriel Steg, Christopher P Cannon, et al.
European Heart Journal|August 2, 2011
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomesRobert F Storey, Richard C Becker, Robert A Harrington, et al.
Pageof 71